Fessler R G, Sturgeon R D, Meltzer H Y
Pharmacol Biochem Behav. 1980 Dec;13(6):835-42. doi: 10.1016/0091-3057(80)90216-6.
The effects and interactions of phencyclidine (PCP), methylphenidate and d-amphetamine on locomotor activity, stereotyped behavior and ataxia in reserpine- and vehicle-pretreated rats were examined. The behaviors of rats receiving PCP alone or in combination with other drugs were quantified along three dimensions (locomotor activity, stereotyped behavior, and ataxia) on scales developed in this laboratory. The behaviors of groups receiving methylphenidate and/or d-amphetamine in treatment combinations other than those including PCP were quantified using a well known d-amphetamine behavioral rating scale. PCP, methylphenidate and d-amphetamine each induced significant increases in locomotor activity and stereotyped behavior when administered alone. Reserpine was found to antagonize PCP-induced locomotor activity and stereotyped behavior, and methylphenidate-induced stereotyped behavior at a dose which either potentiated or had no significant effect upon d-amphetamine-induced behavior (depending upon the scale used). Reserpine also potentiated PCP-induced ataxia. Whereas PCP potentiated the locomotor activity induced by d-amphetamine in both reserpine- and vehicle-pretreated subjects, methylphenidate marginally antagonized d-amphetamine-induced stereotypy in reserpine-pretreated subjects. PCP-induced ataxia in reserpine pretreated subjects appeared moderately reduced in subjects also receiving d-amphetamine. In general, the behavioral effects of PCP appear to be more similar to those of methylphenidate than to those of d-amphetamine, but differences are also found between PCP and methylphenidate. The results are discussed in relation to a behavioral model recently proposed as a method for differentiating indirect dopamine agonists on the basis of their neurochemical mechanisms of action.
研究了苯环利定(PCP)、哌醋甲酯和右旋苯丙胺对利血平预处理和未预处理大鼠的运动活性、刻板行为和共济失调的影响及相互作用。单独给予PCP或与其他药物联合给予时,大鼠的行为在本实验室制定的量表上沿着三个维度(运动活性、刻板行为和共济失调)进行量化。接受哌醋甲酯和/或右旋苯丙胺且治疗组合中不包括PCP的组的行为,使用一种知名的右旋苯丙胺行为评分量表进行量化。单独给予PCP、哌醋甲酯和右旋苯丙胺时,均能显著增加运动活性和刻板行为。发现利血平在对右旋苯丙胺诱导的行为有增强作用或无显著影响的剂量下(取决于所使用的量表),可拮抗PCP诱导的运动活性和刻板行为以及哌醋甲酯诱导的刻板行为。利血平还增强了PCP诱导的共济失调。虽然PCP在利血平预处理和未预处理的受试者中均增强了右旋苯丙胺诱导的运动活性,但哌醋甲酯在利血平预处理的受试者中对右旋苯丙胺诱导的刻板行为有轻微拮抗作用。在同时接受右旋苯丙胺的利血平预处理受试者中,PCP诱导的共济失调似乎有所减轻。总体而言,PCP的行为效应似乎与哌醋甲酯的更相似,而与右旋苯丙胺的不同,但PCP和哌醋甲酯之间也存在差异。结合最近提出的一种行为模型对结果进行了讨论,该模型作为一种基于间接多巴胺激动剂的神经化学作用机制来区分它们的方法。